With the most intuitive end-to-end solution on the market, we have programs available for Gastroenterology, private insurance (adjudication), Medicare, workers’ comp, cash, PI, and manufacturer discount cards. By utilizing our in-house Point of Care physician dispensing solution, your facility can provide needed medications immediately to your patients, improve outcomes & compliance, reduce pharmacy call backs, operational redundancy, and long lines and wait times for your patients at the pharmacy.
Studies show that as many as 40% of patients do not adhere to their treatment regimens, 30% of prescriptions sent to the pharmacy are never filled, and that more than 75% of patients would prefer receiving their medications during their office visit.
Doctor Dispense has programs available for private insurance, Medicare, workers’ comp and cash practices. We have expertise in all areas of pharmaceutical programs that can be tailored to meet the needs of your facility.
Services We Offer
Doctor Dispense has services available for Private, Medicare, Workers' Comp and Cash practices. We have expertise in all areas of pharmaceutical programs that can be tailored to meet the needs of your facility.
“Dr. Dispense has been so helpful in managing our in-office dispensing. We don’t have to worry about keeping track of stock, end-of-month inventory, or ordering. They make dispensing the easiest part of our practice. And the support staff is wonderful!”
“Our organization has utilized Doctor Dispense for a number of years, allowing us to provide a marketable, profitable service to our clients, even in CA. Their customer service is excellent, as they are willing to assist with each new challenge.”
“With all the recent rules and regs changes Dr.Dispense has been a major asset in the survival and future of our office. Dr.Dispense’s employees are proficient, helpful, competent, and a pleasure to work with.”
Pembroke Park, FL
DEA takes additional steps to allow increased production
of controlled substances used in COVID-19 care
The Drug Enforcement Administration announced today that it is increasing Aggregate Production Quotas available to pharmaceutical manufacturers for the production of controlled substance medications that are in high demand due to the coronavirus (COVID-19) pandemic. DEA will also approve increases in imports of medications necessary for patients on ventilators.